MedTrace Logo

Serum Markers in Gluten Challenge

NCT00931892 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-06-04

Study results available
· View outcomes & findings →

Summary

1. The purpose of this research study is to evaluate non-invasive markers of celiac disease activity in subjects that are on a gluten-free diet, in remission from celiac disease who undergo gluten challenge.
2. The secondary aims of this protocol are to identify novel mediators important in the pathophysiology of celiac disease and to evaluate changes in metabolism with gluten exposure.

Conditions

Interventions

DIETARY_SUPPLEMENT

Gluten

3g

DIETARY_SUPPLEMENT

Gluten

10g

Sponsors & Collaborators

Principal Investigators

  • Ciaran P Kelly, MD · Beth Israel Deaconess Medical Center

  • Daniel A Leffler, MD, MS · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00931892 on ClinicalTrials.gov